Epidemiological Characterization of Imported Systemic Mycoses Occurred in Korea.

Osong Public Health Res Perspect

Department of Biomedical Laboratory Science, College of Medical Sciences, Konyang University, Daejeon, Korea.

Published: October 2018

AI Article Synopsis

  • A study in Korea aimed to gather epidemiological data on imported systemic mycoses, a serious fungal infection affecting healthy individuals, due to a lack of existing information.
  • From 2008 to 2012, the prevalence of imported systemic mycoses rose slightly, with coccidioidomycosis showing the most significant increase, particularly among children and the elderly, and varying by region.
  • Treatment costs for these infections were substantial, with most patients being treated as outpatients, and the study's findings may help track trends in imported systemic mycoses over time.

Article Abstract

Objectives: Imported systemic mycoses is a severe fungal infection that can cause diseases in healthy people. However, there is a serious lack of epidemiological data about imported systemic mycoses. Therefore, an epidemiological characterization of imported systemic mycoses in Korea was performed.

Methods: We collected health insurance data between 2008 and 2012 from the Health Insurance Corporation and analyzed the data to determine the prevalence and treatment management of imported systemic mycoses.

Results: The prevalence of imported systemic mycoses between 2008 and 2012 increased slowly by 0.49/100,000 to 0.53/100,000 persons. The prevalence of coccidioidomycosis increased from 0.28/100,000 in 2008 to 0.36/100,000 persons in 2012. A mean of 229.6 cases occurred each year. Children and the elderly showed higher prevalence than adults in the 20- to 59-year-old age group. The rate of infection according to region ranged from 0.18/100,000 persons in Ulsan, to 0.59/100,000 persons in Gyeonggi. The prevalence in females was higher than that in males. Inpatient treatment was 3.3% (38 cases), with 96.7% treated as outpatients. Hospitalizations cost 272.7 million won and outpatient treatments cost 111.7 million won. The treatment cost for coccidioidomycosis from 2008 to 2012 was 330.9 million won, with personal charges of 79.2 million won and insurance charges of 251.7 million won. Most of the expenses for the coccidioidomycosis treatment were for inpatient treatment.

Conclusion: The results in this study may be a useful resource for determining the changes in the trend of imported systemic mycoses.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202016PMC
http://dx.doi.org/10.24171/j.phrp.2018.9.5.07DOI Listing

Publication Analysis

Top Keywords

imported systemic
28
systemic mycoses
24
2008 2012
12
epidemiological characterization
8
characterization imported
8
health insurance
8
imported
7
systemic
7
mycoses
6
prevalence
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!